Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India.

Dharna GuptaNidhi GuptaNavneet SinghShankar Prinja
Published in: JCO global oncology (2024)
-positive NSCLC, respectively.